SAIC Pengajuan SEC - Science Applications International Corporation- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	549300LZPNZIXQGZPZ48
CIK	1571123

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Science Applications International Corporation

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

September 4, 2025	EX-99.1	Three Months Ended August 1, 2025 Percent change August 2, 2024 (dollars in millions, except per share amounts) Revenues $ 1,769 (3)% $ 1,818 Operating income 139 4% 134 Operating income as a percentage of revenues 7.9 % 50bps 7.4 % Adjusted operatin Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2026 Results •Revenues of $1.77 billion; approximately (3)% revenue contraction •Net bookings of $2.6 billion; book-to-bill ratio of 1.5, trailing twelve months book-to-bill ratio of 1.0 •Year-to-date net bookings of $5.0 billion; year-to-date book-to-bill ratio of 1.4 •Net income of $127 million; Adjusted EBITDA(1) of $185 million or 10.5%
September 4, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2025 Science Applica UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I
September 4, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 1, 2025 ☐ TRANSITION REPORT P UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 1, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Ap
August 29, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Science Applicati UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inc
August 29, 2025	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend RESTON, Va., Aug. 29, 2025 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on October 24, 2025 to stockholders of record on October 10, 2025. SAIC intends to continue paying dividends on a quart
July 24, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2025 Science Application UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor
June 18, 2025	11-K	t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address
June 9, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2025 Science Applications UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 2, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 2, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 2, 2025 ☐ TRANSITION REPORT PURS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 2, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Appli
June 2, 2025	EX-99.1	Three Months Ended May 2, 2025 Percent change May 3, 2024 (dollars in millions, except per share amounts) Revenues $ 1,877 2 % $ 1,847 Operating income 121 (8) % 131 Operating income as a percentage of revenues 6.4 % -70bps 7.1 % Adjusted operating i Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2026 Results •Revenues of $1.88 billion; approximately 2% revenue growth •Net bookings of $2.4 billion; book-to-bill ratio of 1.3 •Net income of $68 million; Adjusted EBITDA(1) of $157 million or 8.4% of revenues •Diluted earnings per share of $1.42; Adjusted diluted earnings per share(1) of $1.92 •Cash flows provided by operating activities
May 30, 2025	EX-1.01	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 461932921 (Sta UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 461932921 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 12010 Sunset Hills Road, Reston, Virginia 201
May 30, 2025	SD	SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2024 to December 31, 2024 Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2024 to December 31, 2024 This Conflict Minerals Report (this “Report”) of Science Applications International Corporation (herein referred to as the “Company,” “we,” “us,” or “our”), has been prepared pursuant to Rule 13p-1 (the “Rule”) and Form SD promulgated under the Sec
May 30, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 Science Applications UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
May 30, 2025	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend RESTON, Va., May 30, 2025 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on July 25, 2025 to stockholders of record on July 11, 2025. SAIC intends to continue paying dividends on a quarterly ba
April 23, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240.
April 23, 2025	DEF 14A	DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒Definitive Proxy Statement ☐Definitive Additional Materials ☐Soliciting Material Pursuant to § 240.
March 17, 2025	EX-19	Insider Trading Policies and Procedures. SAIC INSTRUCTION SI-POL1-04 INSIDER TRADING COMPLIANCE AND DISCLOSURE SI-POL1-04 V1.
March 17, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35832 Science Applicat
March 17, 2025	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 17, 2025	EX-99.1	CURRENT Fiscal Year PRIOR Fiscal Year 2026 Guidance 2026 Targets Revenue $7.60B - $7.75B $7.55B - $7.75B Adjusted EBITDA(1) $715M - $735M ~$720M Adjusted EBITDA Margin %(1) 9.4% - 9.6% 9.3% - 9.5% Adjusted Diluted EPS(1) $9.10 - $9.30 $8.90 - $9.10 F Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2025 Results •Q4 FY25 revenues of $1.84 billion, 5.8% organic growth(1); FY25 revenues of $7.48 billion, 3.1% organic growth(1); organic growth adjusted for divestitures •Q4 FY25 net income of $98 million, adjusted EBITDA(1) of $177 million or 9.6% of revenue; FY25 net income of $362 million, adjusted EBITDA(1) of $710 million or 9.5%
March 17, 2025	EX-21	Subsidiaries of Registrant. Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc.
March 14, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 Science Applicatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 14, 2025	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend Reston, Va., Mar. 14, 2025 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on April 25, 2025 to stockholders of record on April 11, 2025. SAIC intends to continue paying dividends on a quarterly
February 10, 2025	EX-99	JOINT FILING AGREEMENT JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Science Applications International Corporation is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.
January 6, 2025	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 2, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of inc
December 5, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In
December 5, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 1, 2024 ☐ TRANSITION REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 1, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science
December 5, 2024	EX-99.1	Three Months Ended November 1, 2024 Percent change November 3, 2023 (in millions, except per share amounts) Revenues $ 1,976 4 % $ 1,895 Operating income 160 12 % 143 Operating income as a percentage of revenues 8.1 % 60 bps 7.5 % Adjusted operating Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2025 Results •Revenues of $1.98 billion; 4.3% revenue growth •Net income of $106 million; Adjusted EBITDA(1) of $197 million or 10.0% of revenues •Diluted earnings per share of $2.13; Adjusted diluted earnings per share(1) of $2.61 •Cash flows provided by operating activities of $143 million; free cash flow(1) of $9 million •Net bookings of
December 4, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In
December 4, 2024	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend Reston, Va., Dec. 04, 2024 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on January 24, 2025 to stockholders of record on January 10, 2025. SAIC intends to continue paying dividends on a quart
November 18, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of i
November 14, 2024	SC 13G/A	SAIC / Science Applications International Corporation / Boston Partners - BOSTON PARTNERS Passive Investment SC 13G/A 1 saica5111424.htm BOSTON PARTNERS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the
November 12, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of in
November 8, 2024	EX-99	JOINT FILING AGREEMENT JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Science Applications International Corporation is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.
November 8, 2024	SC 13G/A	SAIC / Science Applications International Corporation / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6 )* Science Applications International Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement)
October 22, 2024	EX-10.1	, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on Exhibit 10.1 Execution Version AMERICAS/2024344424.6 SEVENTH AMENDMENT This SEVENTH AMENDMENT, dated as of October 18, 2024 (this “Agreement”), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018 (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, that certain THIRD AMENDMENT, dated as of
October 22, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In
September 5, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 2, 2024 ☐ TRANSITION REPORT P UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 2, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Ap
September 5, 2024	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I
September 5, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2024 Science Applica UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I
September 5, 2024	EX-3.1	Amended and Restated Bylaws. Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K as filed with the SEC on September 5, 2024. Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF SCIENCE APPLICATIONS INTERNATIONAL CORPORATION (a Delaware corporation) As amended, September 4, 2024 TABLE OF CONTENTS Page ARTICLE I 1 SECTION 1.01 REGISTERED OFFICE 1 SECTION 1.02 PRINCIPAL OFFICE 1 SECTION 1.03 OTHER OFFICES 1 ARTICLE II 1 SECTION 2.01 ANNUAL MEETINGS 1 SECTION 2.02 SPECIAL MEETINGS 1 SECTION 2.03 TIME AND PLACE OF MEETINGS 2 SECTION
September 5, 2024	EX-99.1	Three Months Ended August 2, 2024 Percent change August 4, 2023 (in millions, except per share amounts) Revenues $ 1,818 2 % $ 1,784 Operating income 134 (63) % 362 Operating income as a percentage of revenues 7.4 % -1,290 bps 20.3 % Adjusted operati Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2025 Results •Revenues of $1.82 billion; 2% organic growth •Net income of $81 million; Adjusted EBITDA(1) of $170 million or 9.4% of revenues •Diluted earnings per share of $1.58; Adjusted diluted earnings per share(1) of $2.05 •Cash flows provided by operating activities of $138 million; free cash flow(1) of $241 million •Net bookings of $
August 30, 2024	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 August 30, 2024 SAIC Board of Directors Declares Cash Dividend Reston, Va., August 30, 2024 – Science Applications International Corp. (Nasdaq: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on October 25, 2024 to stockholders of record on October 11, 2024. SAIC intends to continue paying di
August 30, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inc
June 20, 2024	11-K	t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address
June 11, 2024	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 3, 2024	EX-10.2	First Amendment to the Science Applications International Corporation Amended and Restated 2013 Employee Stock Purchase Plan, effective March 5, 2024. Exhibit 10.2 AMENDMENT NO. 1 TO THE SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN WHEREAS, Science Applications International Corporation (the “Company”) maintains the Science Applications International Corporation 2013 Employee Stock Purchase (the “Plan”) which was amended and restated effective June 7, 2023; and WHEREAS, the Company wishes to amend the Plan to
June 3, 2024	EX-10.1	First Amendment to the Science Applications International Corporation 2023 Equity Incentive Plan, effective March 5, 2024. Exhibit 10.1 AMENDMENT NO. 1 TO THE SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2023 EQUITY INCENTIVE PLAN WHEREAS, Science Applications International Corporation (the “Company”) maintains the Science Applications International Corporation 2023 Equity Incentive Plan (the “Plan”); and WHEREAS, the Company wishes to amend the Plan to reflect the change in the Company’s listing from the New York S
June 3, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 Science Applications UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 3, 2024	EX-99.1	Three Months Ended May 3, 2024 Percent change May 5, 2023 (in millions, except per share amounts) Revenues $ 1,847 (9) % $ 2,028 Operating income 131 (17) % 157 Operating income as a percentage of revenues 7.1 % -60 bps 7.7 % Adjusted operating incom Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2025 Results •Revenues of $1.85 billion; 0.4% organic growth; organic growth reflects impacts of divestitures •Net income of $77 million; Adjusted EBITDA(1) of $166 million or 9.0% of revenues •Diluted earnings per share of $1.48; Adjusted diluted earnings per share(1) of $1.92 •Cash flows provided by operating activities of $98 million; Tra
June 3, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 3, 2024 ☐ TRANSITION REPORT PURS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 3, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Appli
May 31, 2024	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
May 31, 2024	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 May 31, 2024 SAIC Board of Directors Declares Cash Dividend Reston, Va., May 31, 2024 – Science Applications International Corp. (Nasdaq: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on July 26, 2024 to stockholders of record on July 12, 2024. SAIC intends to continue paying dividends on a
May 24, 2024	EX-1.01	SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2023 to December 31, 2023 Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2023 to December 31, 2023 This Conflict Minerals Report (this “Report”) of Science Applications International Corporation (herein referred to as the “Company,” “we,” “us,” or “our”), has been prepared pursuant to Rule 13p-1 (the “Rule”) and Form SD promulgated under the Sec
May 24, 2024	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 (State or othe UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 (State or other jurisdiction of incorporation) Commission File Number 12010 Sunset Hills Road Reston, Virginia (Address of principal executive offices) 20190 (Zip C
April 24, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.
April 24, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.
April 11, 2024	EX-99.1	April 11, 2024 INTRODUCTION Joseph DeNardi Senior Vice President, Investor Relations & Treasurer 3SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED I Asset-light technology integrator with shareholder-focused capital deployment strategy Forw April 11, 2024 INTRODUCTION Joseph DeNardi Senior Vice President, Investor Relations & Treasurer 3SAIC PROPRIETARY INFORMATION I © SAIC.
April 11, 2024	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 20, 2024	EX-21	Subsidiaries of Registrant. Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc. Delaware TASC Services Corporation Delaware ATAC Services, LLC Delaware SAIC Gemini Huntsville, LLC Delaware Odyssey Drive I, Ltd. California Valinar, LLC Delaware Halfaker and Associates, LLC Virginia Koverse, Inc. Delaware
March 20, 2024	EX-97	Policy Relating to Recovery of Erroneously Awarded Compensation Exhibit 97 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RULE 10D-1 COMPENSATION RECOVERY POLICY Effective October 2, 2023 Pursuant to the Listing Standards of the New York Stock Exchange Amended and Restated Effective March 5, 2024 Pursuant to the Listing Standards of The Nasdaq Stock Market LLC Policy The Board of Directors (the “Board”) of Science Applications International Corporation (the “Company”) has adopted this Compensation Recovery Policy (this “Policy”) to comply with Rule 10D-1 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), the Securities and Exchange Commission regulations promulgated thereunder, and applicable listing standards of The Nasdaq Stock Market LLC ("Nasdaq").
March 20, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 2, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35832 Science Applicat
March 20, 2024	EX-4.1	Description of Securities. Exhibit 4.1 Description of Securities General Science Applications International Corporation (“SAIC,” “us,” “we,” or “our”) is currently authorized to issue up to 1,000,000,000 shares of common stock, par value $0.0001 per share and up to 10,000,000 shares of preferred stock, par value $0.0001 per share. Our common stock is registered under Section 12(b) of the Exchange Act. The following summary
March 18, 2024	EX-99.1	PRIOR CURRENT Fiscal Year Fiscal Year 2025 Guidance 2025 Guidance Revenue $7.25B - $7.40B $7.35B - $7.50B Adjusted EBITDA(1) - $680M - $700M Adjusted EBITDA Margin %(1) 9.4% - 9.6% 9.2% - 9.4% Adjusted Diluted EPS(1) $8.00 - $8.20 $8.00 - $8.20 Free Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2024 Results •Q4 FY24 revenues of $1.74 billion, 7.7% organic growth(1); FY24 revenues of $7.44 billion, 7.4% organic growth(1); organic growth reflects impacts of divestitures and additional five working days in the prior year •Q4 FY24 net income of $39 million, adjusted EBITDA(1) of $127 million or 7.3% of revenue; FY24 net income o
March 18, 2024	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 15, 2024	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 March 15, 2024 SAIC Board of Directors Declares Cash Dividend Reston, Va., March 15, 2024 – Science Applications International Corp. (Nasdaq: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on April 26, 2024 to stockholders of record on April 12, 2024. SAIC intends to continue paying dividend
March 15, 2024	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 Science Applicatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 4, 2024	25	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35832 Science Applications UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35832 Science Applications International Corporation New York Stock Exchange (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed an
March 4, 2024	8-A12B	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Science Applications International Corporatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 46-1932921 (State or other jurisdiction of incorporation) (I.R.S. Employer Identific
February 20, 2024	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 Science Applications International Corporation (Exact name of registrant as specified in charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor
February 20, 2024	EX-99.1	SAIC to Host Investor Day in New York City on April 11, 2024 Company also plans to transfer stock market listing to Nasdaq Exhibit 99.1 February 20, 2024 SAIC to Host Investor Day in New York City on April 11, 2024 Company also plans to transfer stock market listing to Nasdaq Reston, Va., February 20, 2024 – Science Applications International Corp. (NYSE: SAIC) announces that it will hold an Investor Day on Thursday, April 11, 2024 and that the company will transfer its stock exchange listing from the New York Stock E
February 13, 2024	SC 13G/A	SAIC / Science Applications International Corporation / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment SC 13G/A 1 saica421324.htm ROBECO INVESTMENT MANAGEMENT INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Stat
February 13, 2024	SC 13G/A	SAIC / Science Applications International Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01884-scienceapplicationsi.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Science Applications International Corp Title of Class of Securities: Common Stock CUSIP Number: 808625107 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the a
February 12, 2024	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In
February 12, 2024	EX-10.1	Sixth Amendment to the Third Amended and Restated Credit Agreement, dated February 8, 2024, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on February 12, 2024. Exhibit 10.1 Execution Version SIXTH AMENDMENT This SIXTH AMENDMENT, dated as of February 8, 2024 (this “Agreement”), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018, (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, that certain THIRD AMENDMENT, dated as of March 1, 2021, that cert
February 8, 2024	SC 13G/A	SAIC / Science Applications International Corporation / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check th
December 11, 2023	EX-99.1	SAIC to Realign Organization to Optimize Strategic Pivots and Increase Organic Growth Exhibit 99.1 FOR IMMEDIATE RELEASE December 11, 2023 SAIC to Realign Organization to Optimize Strategic Pivots and Increase Organic Growth HIGHLIGHTS • Five new business groups to replace two current business sectors • New business groups to include Army; Navy; Air Force and Combatant Commands; Space and Intelligence; and Civilian • Realigned organization will seek to reduce hierarchy, increase in
December 11, 2023	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of i
December 4, 2023	EX-99.1	Three Months Ended November 3, 2023 Percent change October 28, 2022 (in millions, except per share amounts) Revenues $ 1,895 (1) % $ 1,909 Operating income 143 8 % 133 Operating income as a percentage of revenues 7.5 % 50 bps 7.0 % Adjusted operating Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2024 Results •Revenues of $1.90 billion; 10.6% organic growth adjusted for impact of divestitures •Net income of $93 million; Adjusted EBITDA(1) of $178 million or 9.4% as a % of revenues, an increase of 50 bps year-over-year •Diluted earnings per share of $1.76; Adjusted diluted earnings per share(1) of $2.27 •Cash flows provided by operati
December 4, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2023 Science Applicat UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In
December 4, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 3, 2023 ☐ TRANSITION REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 3, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science
December 1, 2023	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 December 1, 2023 SAIC Board of Directors Declares Cash Dividend Reston, Va., December 1, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on January 26, 2024 to stockholders of record on January 12, 2024. SAIC intends to continue paying di
December 1, 2023	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I
September 8, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of i
September 7, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 4, 2023 ☐ TRANSITION REPORT P UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 4, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Ap
September 7, 2023	EX-99.1	Three Months Ended August 4, 2023 Percent change July 29, 2022 (in millions, except per share amounts) Revenues $ 1,784 (3) % $ 1,831 Operating income 362 190 % 125 Operating income as a percentage of revenues 20.3 % 1,350 bps 6.8 % Adjusted operatin Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2024 Results •Revenues of $1.78 billion; 8.3% organic growth adjusted for impact of divestitures •Net income of $247 million; Adjusted EBITDA(1) of $174 million or 9.8% as a % of revenues, an increase of 70 bps year-over-year •Diluted earnings per share of $4.56; Adjusted diluted earnings per share(1) of $2.05 •Cash flows provided by operat
September 7, 2023	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I
June 29, 2023	S-8 POS	As filed with the Securities and Exchange Commission on June 29, 2023 S-8 POS As filed with the Securities and Exchange Commission on June 29, 2023 Registration No.
June 29, 2023	EX-FILING FEES	Calculation of Filing Fee Table. EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Science Applications International Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of
June 29, 2023	11-K	t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address
June 29, 2023	S-8	As filed with the Securities and Exchange Commission on June 29, 2023 S-8 As filed with the Securities and Exchange Commission on June 29, 2023 Registration No.
June 13, 2023	EX-10.3	Form of Performance Stock Unit Award Agreement of the Science Applications International Corporation 2023 Equity Incentive Plan. Incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the SEC on June 13, 2023. Exhibit 10.3 FORM PSU AGREEMENT SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2023 EQUITY INCENTIVE PLAN FY – FY PERFORMANCE STOCK UNIT AWARD AGREEMENT BY ACCEPTING THE AWARD DESCRIBED IN THIS AGREEMENT, RECIPIENT VOLUNTARILY AGREES TO ALL OF THE TERMS AND CONDITIONS SET FORTH IN THE 2023 EQUITY INCENTIVE PLAN AND THIS AGREEMENT. This Award for Performance Stock Units (PSUs) is granted pursuant t
June 13, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 Science Applications UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 13, 2023	EX-10.2	Form of Restricted Stock Unit Award Agreement of the Science Applications International Corporation 2023 Equity Incentive Plan. Incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the SEC on June 13, 2023. Exhibit 10.2 FORM RSU AGREEMENT SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2023 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT BY ACCEPTING THE AWARD DESCRIBED IN THIS AGREEMENT, RECIPIENT VOLUNTARILY AGREES TO ALL OF THE TERMS AND CONDITIONS SET FORTH IN THE 2023 EQUITY INCENTIVE PLAN AND THIS AGREEMENT. This Award for Restricted Stock Units (RSUs) is granted pursuant to the term
June 13, 2023	EX-10.4	Science Applications International Corporation Amended and Restated 2013 Employee Stock Purchase Plan, effective June 7, 2023. Incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K filed with the SEC on June 13, 2023. Exhibit 10.4 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN 1.Amendment and Restatement of Plan. Science Applications International Corporation (the “Company”) restates and amends the Science Applications International Corporation 2013 Employee Stock Purchase Plan (the “Plan”), effective June 7, 2023, to continue to grant options for purchase of Shares as determin
June 7, 2023	EX-4.3	Science Applications International Corporation 2023 Equity Incentive Plan, effective June 7, 2023. Incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-8 (File No. 333-272484) as filed with the Securities and Exchange Commission (SEC) on June 7, 2023. EX-4.3 Exhibit 4.3 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2023 EQUITY INCENTIVE PLAN (1) Purpose of the Plan. The purpose of this 2023 Equity Incentive Plan is to enhance the long-term stockholder value of Science Applications International Corporation and its affiliated companies by offering opportunities to eligible individuals to participate in the growth in value of the equity of Scien
June 7, 2023	S-8	As filed with the Securities and Exchange Commission on June 7, 2023 S-8 As filed with the Securities and Exchange Commission on June 7, 2023 Registration No.
June 7, 2023	EX-FILING FEES	Calculation of Filing Fee Table. EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Science Applications International Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of
June 5, 2023	EX-99.1	Three Months Ended May 5, 2023 Percent change April 29, 2022 (in millions, except per share amounts) Revenues $ 2,028 2 % $ 1,996 Operating income 157 26 % 125 Operating income as a percentage of revenues 7.7 % 140 bps 6.3 % Adjusted operating income Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2024 Results •Revenues of $2.03 billion; 2% revenue growth, 3.5% growth adjusted for impact of deconsolidation of Forfeiture Support Associates joint venture •Net income of $98 million; Adjusted EBITDA(1) of $189 million or 9.3% as a % of revenues •Diluted earnings per share: $1.79; Adjusted diluted earnings per share(1): $2.14 •Net bookings
June 5, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 5, 2023 ☐ TRANSITION REPORT PURS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 5, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Appli
June 5, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2023 Science Applications UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 2, 2023	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 2, 2023	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 June 2, 2023 SAIC Board of Directors Declares Cash Dividend Reston, Va., June 2, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on July 28, 2023 to stockholders of record on July 14, 2023. SAIC intends to continue paying dividends on a q
May 24, 2023	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 (State or other ju UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 (State or other jurisdiction of incorporation) Commission File Number 12010 Sunset Hills Road Reston, Virginia (Address of principal executive offices) 20190 (Zip Code)
May 24, 2023	EX-1.01	SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2022 to December 31, 2022 Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2022 to December 31, 2022 This Conflict Minerals Report (this “Report”) of Science Applications International Corporation (herein referred to as the “Company,” “we,” “us,” or “our”), has been prepared pursuant to Rule 13p-1 (the “Rule”) and Form SD promulgated under the Sec
May 18, 2023	EX-10.1	Transition Letter, dated May 15, 2023. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on May 18, 2023. EX-10.1 Exhibit 10.1 12010 Sunset Hills Rd, Reston, VA 20190 703.676.4300 \| saic.com May 15, 2023 To: Nazzic S. Keene, Chief Executive Officer From: Donna S. Morea, Chair of the Board of Directors RE: Transition and Retirement As we have discussed, we understand your desire to retire from your role as Chief Executive Officer (CEO) and a member of the Board of Directors of SAIC, effective October 2
May 18, 2023	EX-99.1	SAIC Announces CEO Transition Toni Townes-Whitley to become CEO and join SAIC’s Board Nazzic Keene to retire from SAIC following transition period EX-99.1 Exhibit 99.1 SAIC Announces CEO Transition Toni Townes-Whitley to become CEO and join SAIC’s Board Nazzic Keene to retire from SAIC following transition period RESTON, Va.— (BUSINESS WIRE) — Science Applications International Corp. (NYSE: SAIC) today announced the appointment of 35-year global technology veteran Toni Townes-Whitley as the company’s Chief Executive Officer, effective Octobe
May 18, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 Science Applications UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incorp
May 10, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 2) DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
May 8, 2023	EX-99.1	May 8, 2023 Exhibit 99.1 May 8, 2023 SAIC Completes $350 Million Sale of Its Logistics and Supply Chain Management Business to ASRC Federal Reston, Va., May 8, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that it has completed the sale of its Logistics and Supply Chain Management Business to ASRC Federal for $350 million. The divestiture is consistent with SAIC’s broader strate
May 8, 2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorpo
May 5, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.
April 26, 2023	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.
April 26, 2023	DEF 14A	Schedule 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.
April 11, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 Science Applicatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
April 11, 2023	EX-99.1	April 11, 2023 Introduction Joseph DeNardi Vice President, Investor Relations and Strategic Ventures 3SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED IAsset-light technology integrator with shareholder-focused capital deployment strategy C saic2023investorday April 11, 2023 Introduction Joseph DeNardi Vice President, Investor Relations and Strategic Ventures 3SAIC PROPRIETARY INFORMATION I © SAIC.
April 3, 2023	EX-99.1	PRIOR Estimated Impacts Estimated Impacts CURRENT Fiscal Year from L&SCM sale, from Operating Fiscal Year 2024 Guidance FSA, and Section 174 Performance 2024 Guidance Revenue $7.6B - $7.8B Less $650M(2) Plus $50M - $100M $7.05B - $7.20B Adjusted EBIT Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2023 Results •Q4 of fiscal year 2023 revenues of $1.97 billion, 10% growth over Q4 of fiscal year 2022; fiscal year 2023 revenues of $7.70 billion, 4% growth over fiscal year 2022 •Q4 of fiscal year 2023 diluted earnings per share of $1.34; Adjusted diluted earnings per share(1) of $2.04 •Reported fiscal year 2023 cash flows provided
April 3, 2023	10-K	Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 3, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35832 Science Applicat
April 3, 2023	EX-21	Subsidiaries of Registrant. Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc. Delaware SAIC Gemini Huntsville, LLC Delaware Odyssey Drive I, Ltd. California Valinar, LLC Delaware Forfeiture Support Associates, LLC Delaware Halfaker and Associates, LLC Virginia
April 3, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2023 Science Application UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor
March 29, 2023	EX-99.1	SAIC Board of Directors Declares Cash Dividend Exhibit 99.1 March 29, 2023 SAIC Board of Directors Declares Cash Dividend Reston, Va., March 29, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on April 28, 2023 to stockholders of record on April 14, 2023. SAIC intends to continue paying dividends
March 29, 2023	EX-3.1	Amended and Restated Bylaws. Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K as filed with the Commission on March 29, 2023. Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF SCIENCE APPLICATIONS INTERNATIONAL CORPORATION (a Delaware corporation) As amended, March 29, 2023 TABLE OF CONTENTS Page ARTICLE I 1 SECTION 1.01 REGISTERED OFFICE 1 SECTION 1.02 PRINCIPAL OFFICE 1 SECTION 1.03 OTHER OFFICES 1 ARTICLE II 1 SECTION 2.01 ANNUAL MEETINGS 1 SECTION 2.02 SPECIAL MEETINGS 1 SECTION 2.03 TIME AND PLACE OF MEETINGS 2 SECTION 2.0
March 29, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2023 Science Applicatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 29, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2023 Science Applicatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 23, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2023 Science Applicatio UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 23, 2023	EX-99.1	March 23, 2023 Exhibit 99.1 March 23, 2023 SAIC Signs Definitive Agreement to Sell Its Logistics and Supply Chain Management Business to ASRC Federal for $350 Million Reston, Va., March 23, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that it has signed a definitive agreement to sell its logistics and supply chain management business to ASRC Federal Holding Company, LLC (“ASRC Fed
February 13, 2023	SC 13G/A	SAIC / Science Applications International Corp / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua
February 9, 2023	SC 13G/A	SAIC / Science Applications International Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv01852-scienceapplicationsi.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Science Applications International Corp. Title of Class of Securities: Common Stock CUSIP Number: 808625107 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the a
February 6, 2023	SC 13G/A	SAIC / Science Applications International Corp / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check th
January 9, 2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of inc
December 5, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of in
December 5, 2022	EX-99.1	Three Months Ended Nine Months Ended October 28, 2022 Percent change October 29, 2021 October 28, 2022 Percent change October 29, 2021 (in millions, except per share amounts) Revenues $ 1,909 1 % $ 1,898 $ 5,736 2 % $ 5,612 Operating income 133 17 % Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2023 Results •Net bookings of $2.0 billion resulting in a book-to-bill of 1.1x in the quarter •Revenues of $1.91 billion; 1% revenue growth •Diluted earnings per share: $1.45; Adjusted diluted earnings per share(1): $1.90 •Company increases revenue and adjusted diluted EPS(1) guidance for fiscal year 2023 RESTON, VA, December 5, 2022—Science
December 5, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2022 Science Applicat UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In
December 5, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 28, 2022 ☐ TRANSITION REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 28, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Regi
November 30, 2022	EX-99.1	SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Exhibit 99.1 FOR IMMEDIATE RELEASE November 30, 2022 SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Reston, Va., November 30, 2022 ? Science Applications International Corp. (NYSE: SAIC) announced today that the company?s board of directors declared a cash dividend of $0.37 per share of the company?s common stock payable on January 27, 2023 to stockholders of record on January 13, 2023. SAIC inten
November 30, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I
September 1, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I
September 1, 2022	EX-99.1	Three Months Ended Six Months Ended July 29, 2022 Percent change July 30, 2021 July 29, 2022 Percent change July 30, 2021 (in millions, except per share amounts) Revenues $ 1,831 — % $ 1,836 $ 3,827 3 % $ 3,714 Operating income 125 (6) % 133 250 (5) Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2023 Results ?Net bookings of $2.1 billion resulting in a book-to-bill of 1.1x in the quarter and 1.0x TTM ?Revenues of $1.83 billion, approximately flat with prior year ?Diluted earnings per share: $1.30; Adjusted diluted earnings per share(1): $1.75 ?Company increases revenue and adjusted diluted EPS(1) guidance for fiscal year 2023 RESTO
September 1, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 29, 2022 ☐ TRANSITION REPORT PU UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 29, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registr
August 30, 2022	EX-99.1	SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Exhibit 99.1 FOR IMMEDIATE RELEASE August 30, 2022 SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Reston, Va., August 30, 2022 ? Science Applications International Corp. (NYSE: SAIC) announced today that the company?s board of directors declared a cash dividend of $0.37 per share of the company?s common stock payable on October 28, 2022 to stockholders of record on October 14, 2022. SAIC intends t
August 30, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inc
June 30, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor
June 30, 2022	EX-10.1	Fifth Amendment to the Third Amended and Restated Credit Agreement, dated June 30, 2022, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on June 30, 2022. Exhibit 10.1 EXECUTION VERSION FIFTH AMENDMENT This FIFTH AMENDMENT, dated as of June 30, 2022 (this ?Agreement?), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018, (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, that certain THIRD AMENDMENT, dated as of March 1, 2021 and that cert
June 27, 2022	EX-99.1	SAIC Appoints Hilary L. Hageman as Executive Vice President, General Counsel, and Corporate Secretary Exhibit 99.1 SAIC Appoints Hilary L. Hageman as Executive Vice President, General Counsel, and Corporate Secretary RESTON, Va.?(BUSINESS WIRE)? Science Applications International Corp. (NYSE: SAIC) today announces the appointment of Hilary L. Hageman as Executive Vice President, General Counsel, and Corporate Secretary, effective July 11, 2022. Steven G. Mahon, SAIC?s Executive Vice President, Gen
June 27, 2022	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor
June 22, 2022	11-K	t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address
June 21, 2022	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor
June 21, 2022	EX-99.1	FIFTH AMENDMENT Exhibit 99.1 FIFTH AMENDMENT This FIFTH AMENDMENT, dated as of June [30], 2022 (this ?Agreement?), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018, (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, that certain THIRD AMENDMENT, dated as of March 1, 2021 and that certain FOURTH AMEND
June 9, 2022	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 6, 2022	EX-99.1	Three Months Ended April 29, 2022 Percent change April 30, 2021 (in millions, except per share amounts) Revenues $ 1,996 6 % $ 1,878 Operating income 125 (4) % 130 Operating income as a percentage of revenues 6.3 % -60 bps 6.9 % Adjusted operating in Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2023 Results ?Revenues increase to $2.0 billion; 6% total revenue growth, approximately 4% growth excluding acquired revenues ?Diluted earnings per share: $1.29; Adjusted diluted earnings per share(1): $1.88 ?Company increases revenue and adjusted diluted EPS(1) guidance for fiscal year 2023 ?Board authorizes share repurchase program up to 8
June 6, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 29, 2022 ☐ TRANSITION REPORT P UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 29, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Regist
June 6, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
May 31, 2022	EX-99.1	SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Exhibit 99.1 FOR IMMEDIATE RELEASE May 31, 2022 SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Reston, Va., May 31, 2022 ? Science Applications International Corp. (NYSE: SAIC) announced today that the company?s board of directors declared a cash dividend of $0.37 per share of the company?s common stock payable on July 29, 2022 to stockholders of record on July 15, 2022. SAIC intends to continue p
May 31, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
May 25, 2022	EX-1.01	SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2021 to December 31, 2021 Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2021 to December 31, 2021 This Conflict Minerals Report (this ?Report?) of Science Applications International Corporation (herein referred to as the ?Company,? ?we,? ?us,? or ?our?), has been prepared pursuant to Rule 13p-1 (the ?Rule?) and Form SD promulgated under the Sec
May 25, 2022	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 46-1932921 (State UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 46-1932921 (State or other jurisdiction of incorporation or organization) Commission File Number (I.R.S. Employer Identification No.) 12010 Sunset Hills Road Reston, Vi
April 27, 2022	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement x Definitive Additional Materials ? Soliciting Material Pursuant to ? 240.
April 27, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 DEF 14A 1 saic2022proxy.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as pe
April 11, 2022	SC 13G/A	SAIC / Science Applications International Corp / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) March 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant
March 28, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 28, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registrant a
March 28, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 28, 2022	EX-10.21	Form of Restricted Stock Unit Award Agreement of the Science Applications International Corporation 2013 Amended and Restated Equity Incentive Plan. Incorporated by reference to Exhibit 10.21 to the Company’s Annual Report on Form 10-K as filed with the SEC on March 28, 2022. Exhibit 10.21 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2013 AMENDED AND RESTATED EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT BY ACCEPTING THIS AWARD, YOU VOLUNTARILY AGREE TO ALL OF THE TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT AND IN THE PLAN. Science Applications International Corporation, a Delaware corporation (the ?Company?), hereby grants to the participant named
March 28, 2022	EX-99.1	Fiscal Year 2023 Guidance Revenue $7.35 billion to $7.55 billion Adjusted EBITDA Margin(1) Approximately 8.9% Adjusted Diluted EPS(1) $6.80 to $7.10 Free Cash Flow(1) $500 million to $530 million Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2022 Results ?Q4 revenues of $1.8 billion, 4% growth; FY22 revenues of $7.4 billion, 5% growth ?Q4 adjusted EBITDA(1) as a % of revenues of 8.2%; 9.3% for fiscal year 2022 ?Q4 diluted earnings per share: $0.76; adjusted diluted earnings per share(1): $1.50 ?Book to bill of 1.2 for the fourth quarter; 1.3 for fiscal year 2022; backlog
March 28, 2022	EX-21	Subsidiaries of Registrant. Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc. Delaware SAIC Gemini Huntsville, LLC Delaware Odyssey Drive I, Ltd. California Valinar, LLC Delaware Forfeiture Support Associates, LLC Delaware Halfaker and Associates, LLC Virginia
March 28, 2022	EX-10.22	Form of Performance Share Award Agreement of the Science Applications International Corporation 2013 Amended and Restated Equity Incentive Plan. Incorporated by reference to Exhibit 10.22 to the Company’s Annual Report on Form 10-K as filed with the SEC on March 28, 2022. Exhibit 10.22 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2013 AMENDED AND RESTATED EQUITY INCENTIVE PLAN PERFORMANCE SHARE AWARD AGREEMENT BY ACCEPTING THE AWARD DESCRIBED IN THIS AGREEMENT, YOU VOLUNTARILY AGREE TO ALL OF THE TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT, THE AWARD GRANT NOTICE AND IN THE PLAN. This Performance Share Award Agreement (this ?Agreement?), effective as of the
March 23, 2022	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 23, 2022	EX-99.1	SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Exhibit 99.1 FOR IMMEDIATE RELEASE March 23, 2022 SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Reston, Va., March 23, 2022 ? Science Applications International Corp. (NYSE: SAIC) announced today that the company?s board of directors declared a cash dividend of $0.37 per share of the company?s common stock payable on April 29, 2022 to stockholders of record on April 14, 2022. SAIC intends to cont
February 11, 2022	SC 13G/A	SAIC / Science Applications International Corp / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua
February 10, 2022	SC 13G/A	SAIC / Science Applications International Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Science Applications International Corp. Title of Class of Securities: Common Stock CUSIP Number: 808625107 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this
February 4, 2022	SC 13G/A	SAIC / Science Applications International Corp / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu
December 6, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 29, 2021 ☐ TRANSITION REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 29, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Regi
December 6, 2021	EX-99.1	Three Months Ended Nine Months Ended October 29, 2021 Percent change October 30, 2020 October 29, 2021 Percent change October 30, 2020 (in millions, except per share amounts) Revenues $ 1,898 4 % $ 1,818 $ 5,612 5 % $ 5,339 Operating income 114 4 % 1 Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2022 Results ?Revenues increase to $1.9 billion; 4.4% total revenue growth, 2.1% growth excluding acquired revenues ?Diluted earnings per share increase to $1.22; Adjusted diluted earnings per share(1) increase to $1.85 ?Company raises revenue, adjusted EBITDA margin(1), adjusted diluted EPS(1), and free cash flow(1) guidance for fiscal year
December 6, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In
September 3, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 30, 2021 ☐ TRANSITION REPORT PU UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registr
September 2, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I
September 2, 2021	EX-99.1	Three Months Ended Six Months Ended July 30, 2021 Percent change July 31, 2020 July 30, 2021 Percent change July 31, 2020 (in millions, except per share amounts) Revenues $ 1,836 4 % $ 1,764 $ 3,714 5 % $ 3,521 Operating income 133 33 % 100 263 48 % Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2022 Results ?Revenues increase to $1.8 billion; 4.1% total revenue growth, 3.8% growth excluding acquired revenues ?Diluted earnings per share increase to $1.41; Adjusted diluted earnings per share(1) increase to $1.97 ?Net bookings of $1.6 billion; Book-to-bill ratio of 0.9 for the second quarter ?Company raises revenue, adjusted EBITDA m
July 7, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
July 7, 2021	EX-10.1	Fourth Amendment to the Third Amended and Restated Credit Agreement, dated July 2, 2021, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on July 7, 2021. Exhibit 10.1 Execution Version FOURTH AMENDMENT This FOURTH AMENDMENT, dated as of July 2, 2021 (this ?Agreement?), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018, (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, and that certain THIRD AMENDMENT, dated as of March 1, 2021 and as o
June 29, 2021	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor
June 29, 2021	EX-99.1	JUNE 29, 2021 Exhibit 99.1 FOR IMMEDIATE RELEASE JUNE 29, 2021 SAIC APPOINTS NEW BOARD MEMBER MILFORD MCGUIRT New SAIC board member brings decades of public accounting and auditing experience and years of overseeing exceptional client service delivery Reston, Va., JUNE 29, 2021 ? Science Applications International Corp. (NYSE: SAIC) today announced the appointment of Milford W. McGuirt, retired managing partner
June 24, 2021	11-K	t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address
June 4, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incorp
June 4, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2021 ☐ TRANSITION REPORT P UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Regist
June 3, 2021	EX-99.1	Three Months Ended April 30, 2021 Percent change May 1, 2020 (in millions, except per share amounts) Revenues $ 1,878 7 % $ 1,757 Operating income 130 67 % 78 Operating income as a percentage of revenues 6.9 % 250 bps 4.4 % Adjusted operating income( Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2022 Results ?Revenues increase to $1.9 billion; ~7% total revenue growth, 2.6% growth excluding acquired revenues ?Diluted earnings per share increase to $1.38; Adjusted diluted earnings per share(1) increase to $1.94 ?Net bookings of $4.2 billion; Book-to-bill ratio of 2.2 for the first quarter ?Company increases lower end of revenue and a
June 3, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
May 25, 2021	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 46-1932921 (State UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 46-1932921 (State or other jurisdiction of incorporation or organization) Commission File Number (I.R.S. Employer Identification No.) 12010 Sunset Hills Road Reston, Vi
May 25, 2021	EX-1.01	SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2020 to December 31, 2020 Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2020 to December 31, 2020 This Conflict Minerals Report (this ?Report?) of Science Applications International Corporation (herein referred to as the ?Company,? ?we,? ?us,? or ?our?), has been prepared pursuant to Rule 13p-1 (the ?Rule?) and Form SD promulgated under the Sec
April 21, 2021	DEF 14A	- DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to ? 240.
April 21, 2021	DEFA14A	- DEFA14A DEFA14A 1 saic2021addlproxy.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule
March 26, 2021	EX-21	Subsidiaries of Registrant. Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc. Delaware SAIC Gemini Huntsville, LLC Delaware Odyssey Drive I, Ltd. California Valinar, LLC Delaware Engility Services, LLC Delaware Engility LLC Delaware Forfeiture Support Associates, LLC Delaware
March 26, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 29, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registrant a
March 25, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 25, 2021	EX-99.1	Fiscal Year 2022 Guidance Revenue $7.1 billion to $7.3 billion Adjusted EBITDA Margin(1) 8.6% to 8.8% Adjusted Diluted EPS(1) $6.00 to $6.25 Free Cash Flow(1) $430 million to $470 million Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2021 Results Q4 Revenues of $1.7 billion; 11 percent growth Q4 Diluted earnings per share: $1.05; adjusted diluted earnings per share(1): $1.67 Q4 Adjusted EBITDA(1) as a % of revenues of 9.3%; 8.9% for fiscal year 2021 Book to bill of 0.4 for the fourth quarter; 1.7 for fiscal year 2021 Share repurchases re-initiated during the fourt
March 15, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of inco
March 5, 2021	EX-10.1	Third Amendment to the Third Amended and Restated Credit Agreement, dated March 1, 2021, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on March 5, 2021. Exhibit 10.1 Execution Version THIRD AMENDMENT This THIRD AMENDMENT, dated as of March 1, 2021 (this ?Agreement?), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018 (as amended by the FIRST AMENDMENT, dated as of February 19, 2020, as further amended by the SECOND AMENDMENT, dated as of March 13, 2020, and as otherwise amended from time to time prior to the date hereo
March 5, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor
February 16, 2021	CORRESP	- CORRESP 1 filename1.htm Prabu Natarajan Chief Financial Officer Science Applications International Corporation 12010 Sunset Hills Road Reston, VA 20190 February 16, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street NE Washington, D.C. 20549 Attn: Kathryn Jacobson Robert Littlepage RE: Science Applications International
February 12, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of i
February 12, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Science Applications International Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule
February 11, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2020 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua
February 10, 2021	SC 13G/A	SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) January 29, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua
February 10, 2021	SC 13G/A	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* SC 13G/A 1 tv01790-scienceapplicationsi.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: Science Applications International Corp. Title of Class of Securities: Common Stock CUSIP Number: 808625107 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the a
February 4, 2021	SC 13G	SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan
February 3, 2021	CORRESP	- CORRESP 1 filename1.htm Prabu Natarajan Chief Financial Officer Science Applications International Corporation 12010 Sunset Hills Road Reston, VA 20190 February 3, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street NE Washington, D.C. 20549 Attn: Kathryn Jacobson Robert Littlepage RE: Science Applications International
January 12, 2021	CORRESP	- Prabu Natarajan Chief Financial Officer Science Applications International Corporation 12010 Sunset Hills Road Reston, VA 20190 January 12, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street NE Washington, D.
December 4, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Regi
December 3, 2020	EX-99.1	Three Months Ended Nine Months Ended October 30, 2020 Percent change November 1, 2019 October 30, 2020 Percent change November 1, 2019 (in millions, except per share amounts) Revenues $ 1,818 12 % $ 1,630 $ 5,339 10 % $ 4,839 Operating income 110 17 Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2021 Results Revenues: $1.8 billion; 12% total revenue growth, 0.7% contraction excluding acquired revenues Diluted earnings per share: $1.02; Adjusted diluted earnings per share(1): $1.62 Adjusted EBITDA(1) as a % of revenues: 9.0% Cash flows provided by operating activities: $231 million, $502 million year to date (excluding sale of receiv
December 3, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In
November 5, 2020	EX-99.1	SAIC Appoints New Chief Financial Officer EX-99.1 Exhibit 99.1 For Immediate Release SAIC Appoints New Chief Financial Officer Prabu Natarajan joins SAIC Executive Leadership Team RESTON, VA—(Business Wire)—Science Applications International Corp. (NYSE: SAIC) today announced the appointment of Prabu Natarajan as executive vice president and chief financial officer, effective January 4, 2021. Natarajan will report to CEO Nazzic Keene and
November 5, 2020	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of in
September 17, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 17, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of
September 3, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registr
September 2, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I
September 2, 2020	EX-99.1	Three Months Ended Six Months Ended July 31, 2020 Percent change August 2, 2019 July 31, 2020 Percent change August 2, 2019 (in millions, except per share amounts) Revenues $ 1,764 11 % $ 1,594 $ 3,521 10 % $ 3,209 Operating income 100 5 % 95 178 (5) Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2021 Results Revenues: $1.8 billion; 11% total revenue growth, 1% contraction excluding acquired revenues Diluted earnings per share: $0.87; Adjusted diluted earnings per share(1): $1.63 Adjusted EBITDA(1) as a % of revenues: 9.5% Cash flows provided by operating activities: $104 million, $271 million year to date (excluding sale of receiva
August 14, 2020	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of inc
August 14, 2020	EX-99.1	SAIC Announces Retirement of Chief Financial Officer Charles A. Mathis EX-99.1 Exhibit 99.1 SAIC Announces Retirement of Chief Financial Officer Charles A. Mathis Reston, Va. – Aug. 14, 2020 – Science Applications International Corporation (NYSE: SAIC) announced today the retirement of Chief Financial Officer Charles A. Mathis. Mathis will remain with the company through fiscal year 2021, ending January 29, 2021, to ensure a smooth transition as the company conducts
July 2, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 28, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor
July 2, 2020	EX-10.1	SAIC Executive Severance, Change in Control and Retirement Policy, effective July 1, 2020. Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on July 2, 2020. EX-10.1 Exhibit 10.1 SAIC EXECUTIVE SEVERANCE, CHANGE IN CONTROL AND RETIREMENT POLICY As of July 1, 2020 (the “Effective Date”) Section 1. Introduction. (a) The purpose of this Executive Severance, Change in Control and Retirement Policy (the “Policy”) is to specify the compensation and benefits payable in connection with certain termination events for Eligible Officers of Science Applications In
June 23, 2020	11-K	- 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address of
June 8, 2020	8-K	Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 5, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 1, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registran
June 4, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp
June 4, 2020	EX-99.1	Three Months Ended May 1, 2020 Percent change May 3, 2019 (in millions, except per share amounts) Revenues $ 1,757 9 % $ 1,615 Operating income 78 (16 )% 93 Operating income as a percentage of revenues 4.4 % -140 bps 5.8 % Adjusted operating income(1 Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2021 Results Revenues: $1.8 billion; 9% total revenue growth, 3% excluding acquired revenues Diluted earnings per share: $0.62; Adjusted diluted earnings per share(1): $1.38 Adjusted EBITDA(1) as a % of revenues: 7.8%, including 30 bps negative impact from COVID-19 Cash flows provided by operating activities: $367 million; $167 million exclu
May 20, 2020	SD	- SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 46-1932921 (State or other jurisdiction of incorporation or organization) Commission File Number (I.R.S. Employer Identification No.) 12010 Sunset Hills Road Reston, Vi
May 20, 2020	EX-1.01	SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2019 to December 31, 2019 Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2019 to December 31, 2019 This Conflict Minerals Report (this “Report”) of Science Applications International Corporation (herein referred to as the “Company,” “we,” “us,” or “our”), has been prepared pursuant to Rule 13p-1 (the “Rule”) and Form SD promulgated under the Sec
April 22, 2020	EX-99.2	Federal (A Business of Unisys Corporation) Combined Financial Statements As of and for the year ended December 31, 2019 Exhibit 99.2 Federal (A Business of Unisys Corporation) Combined Financial Statements As of and for the year ended December 31, 2019 Federal (A Business of Unisys Corporation) (U.S. dollars in millions, except where otherwise noted) Table of Contents Independent Auditors' Report 3 COMBINED STATEMENT OF INCOME 4 COMBINED BALANCE SHEET 5 COMBINED STATEMENT OF CASH FLOWS 6 COMBINED STATEMENT OF CHANG
April 22, 2020	EX-99.3	SCIENCE APPLICATIONS INTERNATIONAL CORPORATION UNAUDITED PRO FORMA CONDENSED, CONSOLIDATED, AND COMBINED FINANCIAL INFORMATION Exhibit 99.3 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION UNAUDITED PRO FORMA CONDENSED, CONSOLIDATED, AND COMBINED FINANCIAL INFORMATION Unaudited Pro Forma Condensed, Consolidated, and Combined Financial Information as of and for the Twelve Months Ended January 31, 2020. The following unaudited pro forma condensed, consolidated, and combined financial statements of Science Applications Interna
April 22, 2020	DEFA14A	SAIC / Science Applications International Corp. DEFA14A - - DEFA14A DEFA14A 1 saic2020addlproxy.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule
April 22, 2020	8-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 202 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other
April 22, 2020	DEF 14A	SAIC / Science Applications International Corp. DEF 14A - - DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.
March 27, 2020	EX-4.1	Description of Securities. Incorporated by reference to Exhibit 4.1 to the Company's Annual Report on Form 10-K as filed with the SEC on March 27, 2020. Exhibit 4.1 Description of Common Stock General Science Applications International Corporation (“SAIC,” “us,” “we,” or “our”) is currently authorized to issue up to 1,000,000,000 shares of common stock, par value $0.0001 per share and up to 10,000,000 shares of preferred stock, par value $0.0001 per share. Our common stock is registered under Section 12(b) of the Exchange Act. The following summar
March 27, 2020	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registrant a
March 27, 2020	EX-21	Subsidiaries of Registrant. EX-21 3 saicexhibit2110-k.htm SUBSIDIARIES Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc. Delaware SAIC Gemini Huntsville, LLC Delaware Odyssey Drive I, Ltd. California Engility Holdings, LLC Delaware Engility Services, LLC Delaware Engility LLC Delaware Forfeiture Support Associates, LLC Delaware
March 26, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): 3/26/2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorpora
March 26, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 26, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 26, 2020	EX-10.1	Amendment No.1 to Master Accounts Receivable Purchase Agreement, dated March 17, 2020, among Science Applications International Corporation, Engility Services, LLC, and MUFG Bank, Ltd. Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on March 26, 2020. Exhibit 10.1 EXECUTION AGREEMENT AMENDMENT NO. 1 TO MASTER ACCOUNTS RECEIVABLE PURCHASE AGREEMENT This AMENDMENT NO. 1 to the MASTER ACCOUNTS RECEIVABLE PURCHASE AGREEMENT (this “Amendment”), dated as of March 17, 2020, is among SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, a Delaware corporation (“SAIC”), as a seller and as seller representative (in such capacity as seller representative, the “
March 26, 2020	EX-99.1	Three Months Ended Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2020 Results Q4 Revenues of $1.5 billion; 29 percent growth Q4 Diluted earnings per share: $1.01; adjusted diluted earnings per share(1) of $1.58 Q4 Adjusted EBITDA(1) as a % of revenues of 8.7%; 8.4% for fiscal year 2020 Q4 Cash flows provided by operating activities of $69 million; $458 million for fiscal year 2020 Fiscal year 2020
March 16, 2020	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 16, 2020	EX-99.1	SAIC Completes Acquisition of Unisys Federal SAIC welcomes approximately 2,000 new employees creating a leading digital transformation provider to the U.S. government. EX-99.1 Exhibit 99.1 March 16, 2020 FOR IMMEDIATE RELEASE SAIC Completes Acquisition of Unisys Federal SAIC welcomes approximately 2,000 new employees creating a leading digital transformation provider to the U.S. government. RESTON, Va., March 16, 2020 — Science Applications International Corporation (NYSE: SAIC) completed its acquisition of Unisys Federal on March 13, 2020 for $1.2 billion in ca
March 16, 2020	EX-10.1	Second Amendment, dated March 13, 2020, to the Third Amended and Restated Credit Agreement, dated October 31, 2018 by and among Science Applications International Corporation, Citibank, N.A., as administrative agent and collateral agent, and certain other agents and lenders party thereto. Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 16, 2020. EX-10.1 Exhibit 10.1 EXECUTION VERSION SECOND AMENDMENT This SECOND AMENDMENT, dated as of March 13, 2020 (this “Agreement”), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018, (as amended by the FIRST AMENDMENT, dated as of February 19, 2020, and as otherwise amended from time to time prior to the date hereof, the “Existing Credit Agreement”), among SCIENCE APPLICATI
March 16, 2020	EX-4.1	Indenture, dated March 13, 2020, by and among Science Applications International Corporation, the guarantors party thereto and U.S. Bank National Association, as trustee. Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 16, 2020. EX-4.1 Exhibit 4.1 Execution Version SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, as Issuer INDENTURE Dated as of March 13, 2020 U.S. BANK NATIONAL ASSOCIATION, as Trustee $400,000,000 4.875% Senior Notes due 2028 TABLE OF CONTENTS Page ARTICLE I Definitions and Incorporation by Reference 1 SECTION 1.1 Definitions 1 SECTION 1.2 Other Definitions 32 SECTION 1.3 Rules of Construction 33 SECTION 1
March 13, 2020	EX-99.1	SAIC and Unisys Announce Expiration of Hart-Scott-Rodino (HSR) Waiting Period for Unisys Federal Transaction EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE SAIC and Unisys Announce Expiration of Hart-Scott-Rodino (HSR) Waiting Period for Unisys Federal Transaction Reston, Va. & Blue Bell, Pa. – {March 13, 2020} Science Applications International Corp. (NYSE: SAIC) and Unisys Corporation (NYSE: UIS) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of
March 13, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco
March 4, 2020	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor
March 4, 2020	EX-99.1	SAIC Announces Pricing of $400.0 Million in Senior Notes EX-99.1 Exhibit 99.1 SAIC Announces Pricing of $400.0 Million in Senior Notes March 4, 2020 RESTON, Va. — (BUSINESS WIRE) — Science Applications International Corp. (NYSE: SAIC) (“SAIC”), a leading technology integrator providing high-end solutions in engineering, IT and mission solutions across the defense, space, civilian and intelligence markets, announced today that it has priced an offering o
March 3, 2020	EX-99.2	SAIC Announces Proposed Offering of $400.0 Million in Senior Notes EX-99.2 Exhibit 99.2 SAIC Announces Proposed Offering of $400.0 Million in Senior Notes March 3, 2020 RESTON, Va. — (BUSINESS WIRE) — Science Applications International Corp. (NYSE: SAIC) (“SAIC”), a leading technology integrator providing high-end solutions in engineering, IT and mission solutions across the defense, space, civilian and intelligence markets, announced today that it intends to com
March 3, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2020 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor
March 3, 2020	EX-99.1	1 EX-99.1 Exhibit 99.1 Recent Developments Preliminary, unaudited estimates for the fiscal year ended January 31, 2020 The following is a preliminary summary of our selected year-end financial data for fiscal 2020. All comparisons are with the year-end financial data for fiscal 2019 unless otherwise stated: • Total backlog is expected to be approximately $15,200 million, compared to $13,801 million
February 27, 2020	EX-99.1	Excerpts from Lender Presentation, dated February 27, 2020. EX-99.1 Exhibit 99.1 Pro Forma LTM Adjusted EBITDA Reconciliation (1) SAIC Unisys Federal Pro Forma Adjustments Pro Forma Combined ($ in M) Revenue $6,031 $726 $292 $7,049 Net Income $160 $49 ($80) 129 Interest Expense $84 - 53 137 Interest Income ($4) - - (4) Income Taxes $50 17 (28) 39 Depreciation & Amortization $114 2 104 220 (2) Acquisition & Integration Costs $95 1 (1) 95 Reported Adjusted E

GB:0V9N
IT:1SAIC	€ 91.50
DE:85S	€ 83.00

SAIC / Science Applications International Corporation - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)

Other Listings